Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Biopsy is crucial for diagnosing unusual hair loss causes like lymphoma.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

FUE hair transplantation is safe and effective for improving hair loss in children.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Adding nano fat to hair transplants improves results for scar-related hair loss.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

There is no standard treatment for CCCA, and practices vary widely.

Brunsting-Perry pemphigoid can cause scarring hair loss and may be underdiagnosed.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Widened sweat ducts are a very specific sign of scarring hair loss.